A long-acting biologic with transmucosal transport properties that arrest SARS-CoV-2 virus variants (IMAGE)
Caption
A pan-SARS-CoV-2 specific soluble ACE2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery
Credit
Figure was made by Sopisa Benjakul, Aina Anthi and Anette Koledrup with the use of BioRender
Usage Restrictions
Figure was made by the use of BioRender
License
Original content